AAAAAA
Results:
1-7
|
Results: 7
Authors:
KOREN MJ
SMITH DG
HUNNINGHAKE DB
DAVIDSON MH
MCKENNEY JM
WEISS SR
SCHROTT HG
HENLEY RW
TRESH P
MCLAIN RW
BAKKERARKEMA RG
BLACK DM
Citation: Mj. Koren et al., THE COST OF REACHING NATIONAL-CHOLESTEROL-EDUCATION-PROGRAM (NCEP) GOALS IN HYPERCHOLESTEROLEMIC PATIENTS - A COMPARISON OF ATORVASTATIN, SIMVASTATIN, LOVASTATIN AND FLUVASTATIN, PharmacoEconomics, 14(1), 1998, pp. 59-70
Authors:
KOREN M
INSULL W
SCHROTT H
DAVILA M
HEINONEN T
MCLAIN RW
BLACK D
Citation: M. Koren et al., ACAT INHIBITOR AVASIMIBE LOWERS VLDL AND TG IN PATIENTS WITH HYPERTRIGLYCERIDEMIA, Circulation, 98(17), 1998, pp. 1243-1243
Authors:
SMITH DG
BAKKERARMEMA RG
MCLAIN RW
KOREN MJ
BLACK DM
Citation: Dg. Smith et al., THE COMPARATIVE EFFECTS OF ATORVASTATIN IN ACHIEVING DESIRED LIPID-LEVELS FOLLOWING NCEP GUIDELINES, American journal of managed care, 3(10), 1997, pp. 8-8
Authors:
SMITH DG
BAKKERARKMEMA RG
MCLAIN RW
BLACK DM
Citation: Dg. Smith et al., THE USE OF ADD-ON TREATMENT IN HMG-COA REDUCTASE INHIBITOR THERAPY TOACHIEVE TARGET LIPID-LEVELS, American journal of managed care, 3(10), 1997, pp. 9-9
Authors:
SMITH DG
BAKKERARKEMA RG
MCLAIN RW
BLACK DM
Citation: Dg. Smith et al., VARIATIONS IN COSTS AMONG PAYERS IN TREATMENT WITH HMG-COA REDUCTASE INHIBITOR THERAPY TO ACHIEVE TARGET LIPID-LEVELS, American journal of managed care, 3(10), 1997, pp. 10-10
Authors:
CANTER DA
TEXTER MJ
MCLAIN RW
Citation: Da. Canter et al., AMBULATORY BLOOD-PRESSURE MONITORING CAN PLAY AN INTEGRAL ROLE IN PATIENT SELECTION, DOSAGE ADJUSTMENT AND EFFICACY ASSESSMENT IN CLINICAL-TRIALS OF ANTIHYPERTENSIVE AGENTS, Journal of hypertension, 12, 1994, pp. 33-38
Authors:
CANTER DA
TEXTER MJ
MCLAIN RW
Citation: Da. Canter et al., SHORT REPORT - AMBULATORY BLOOD-PRESSURE MONITORING CAN PLAY AN INTEGRAL ROLE IN PATIENT SELECTION, DOSAGE ADJUSTMENT AND EFFICACY ASSESSMENT IN CLINICAL-TRIALS OF ANTIHYPERTENSIVE AGENTS, Journal of hypertension, 12(4), 1994, pp. 491-494
Risultati:
1-7
|